Despite people impacted by disease being aware of the benefit many medications provide, over 50% of patients fail to take them as prescribed. When it is human psychology to avoid pain whenever possible, why do patients fail to adhere to medications even when side effects are minimal and knowing there will be a downside risk? There are no easy answers to why but there are several approaches that can be implemented to help people maintain adherence. 

During this discussion, gain insights from experts with more than a decade of experience running industry-leading adherence programs and hear results from Nuvera’s patient services industry benchmarking PURE Report based upon responses from over 4,000 physicians, office staff, and patients across multiple therapeutic areas.

Key learning objectives include:

• Resource Effectiveness & Utilization Discuss how to customize what adherence approaches are used where and when
• Satisfaction & Channel Maximization Explore available communication channels to maximize awareness and impact
• Evolutionary Educational Strategies Understand how educational/support programs need to adapt to shifting needs throughout treatment onboarding and beyond

Speakers:

Jens Kulstad

Manager
Nuvera Life Science Consulting

Nareda Mills

Global President Patient Solutions
Ashfield Engage

Sponsored By:

Nuvera Life Science Consulting, an Ashfield Engage company, helps the world’s leading and up-and-coming pharmaceutical and biotech companies deliver impactful patient and HCP support experiences for specialty and rare-disease therapies. Nuvera excels at uncovering patient/HCP needs that are leveraged to help execute seamless treatment experiences that enhance patients’ ability to obtain, start, and stay on therapies. Nuvera launched The PURE Report in 2019 to evaluate and provide independent industry benchmark of HCP satisfaction, utilization, and evolving needs across patient support programs.